Case Report and Cohort Analysis of Drug-Induced Liver Injury Associated with Daptomycin

Nicole Bohm, Charles T. Makowski, Mario Gutiérrez Machado, Adam Davie, Nelson Seabrook, Lee Wheless, Benjamin T. Bevill, Bradley Clark, T. Rogers Kyle

Antimicrobial Agents and Chemotherapy · 2014 · 18 citations · 3 references

DOIFull text

Open access

Concepts

Abstract

A patient receiving daptomycin developed asymptomatic transaminitis and hyperbilirubinemia without concurrent multiorgan dysfunction or elevation of his creatinine kinase level. After ruling out other etiologies, the liver injury was attributed to daptomycin and was subsequently resolved. A single-center retrospective cohort analysis of baseline and follow-up liver function panels (n = 614) from all admissions from 2008 to 2013 during which daptomycin was administered did not reveal any other cases of probable or definite drug-induced liver injury associated with daptomycin.

References

3